Bronchiolitis obliterans syndrome (BOS)

Bronchiolitis obliterans syndrome (BOS) see more is the single most important factor that limits long-term survival following lung transplantation [1]. We have shown that BOS is associated with lack of immunosuppression of T cell T helper

type 1 (Th1) cell proinflammatory cytokines and increased T cell granzyme B by peripheral blood T cells [2, 3]. Current immunosuppressive therapies target Th1 proinflammatory cells [4]; however, they are relatively non-specific and, as we have shown, ineffective at reducing proinflammatory mediators produced by major lymphocyte subsets in the peripheral blood of lung transplant patients undergoing and preceding diagnosis of BOS [2, 3, 5]. Hence, there is an urgent need for new targeted therapy to prevent BOS. Following PF-6463922 order adhesion and antigen presentation, T cells require co-stimulatory

signals from professional antigen-presenting cells through surface receptors for T cell proliferation and cytokine production [6]. Repeated antigen-driven proliferation down-regulates T cell CD28 and expansion of late-differentiated, antigen-specific, oligoclonal T cells [7]. Recently, we have shown CD28 down-regulation on CD8+ T cells, the main effector T cells in patients with chronic obstructive pulmonary disease (COPD), another important

chronic pulmonary disease [8]. We hypothesized that down-regulation of CD28 (to a ‘CD28null’ phenotype) and corresponding up-regulation of alternate co-stimulatory molecules Glutamate dehydrogenase may play an important role in the generation of steroid-resistant cytotoxic molecules such as granzymes/perforin and proinflammatory cytokine production by T cells in BOS. Down-regulation of CD28 expression following persistent antigenic stimulation has also been shown to be associated with up-regulation of CD57 expression, a terminally sulphated carbohydrate determinant found on subsets of natural killer (NK) cells and NK T-like cells associated with ageing [9]. Interestingly, we have shown recently that there are increased peripheral blood CD56+CD3+ NK T-like cells in blood from stable lung transplant patients and that these cells exhibit increased production of proinflammatory cytokines interferon (IFN)-γ and tumour necrosis factor (TNF)-α and expression of cytotoxic molecules, perforin and granzymes [10]. We hypothesized that dysregulated expression of T cell co-stimulatory molecules may be associated with steroid resistance and BOS, and identify potential new therapeutic targets that are needed urgently to improve the morbidity and mortality rates following lung transplantation.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>